芪参益气滴丸对慢性心力衰竭患者的临床疗效分析.

Objective: To investigate the effect of I. NT-BNP and clinical effect of the treatment of chronic heart failure with Qishenyiqi pills. Methods: 60 cases of patients with chronic heart failure treatment were selected and randomly divided into experimental group and control group with 30 cases in each group, the control group were treated with benazepril hydrochloride tablets 10 mg/time, 1 times/d; Furosemide Tablets 20 mg/time. 1 times /d; metoprolol sustained-release tablets 23.75 mg/time. 1 times / D; atorvastatin 20 mg/ time, 1 times /d; digoxin 0.125 mg/time, 1 times/d; Aspirin Enteric-coated Tablets 100 mg/time, Isosorbide Mononitrate Tablets 20mg/time ltime /d; the patients in the experimental group on the basis of the control group. Qishenyiqi pills, a 1 bag. 3 times /d, for 4 weeks after the end of treatment. The serum NT-BNP. patients with hs-CRP. cTn I levels were detected and compared. Results: Compared with before treatment, after treatment in patients with serum NT-BNP. hs CRP. cTnl water decreased (P<0.05); compared with the control group, patients in the experimental group the serum NT-BNP. hs CRP. cTnl level is low. clinical treatment, the total effective rate was higher (P < 0.05). Conclusion: Qi Shen Qi pill can reduce the serum levels of BNP - hs-CRP. cTn. I NT in patients with chronic heart failure, the clinical efficacy is good, it has guiding significance for clinical. [ABSTRACT FROM AUTHOR]